Effective Pain Management During Shoulder Replacement Surgery With EXPAREL
Status:
Withdrawn
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effectiveness of post-operative pain control of
local infiltration (LIA) of EXPAREL administration to ropivacaine administered via continuous
interscalene nerve block (CINB) for postoperative pain relief following shoulder replacement.
Effectiveness will be measured in opioid consumption and NRS pain intensity scores from 0-4h,
4-8h, 9-12h, 13-16h, 17-20, 21-24h, 48 hours and 72 hours post-op. Patient satisfaction with
pain control; patient functional outcome; adverse events related to CINB, EXPAREL
administration, and opioid consumption; and pain intensity scores from the time of surgery
until post-operative day 10 (+/- 5 days) will also be examined.